/CSL
CSL
Cum-Dividend
Ex-Dividend
Updated 24 Aug 08:16 am
$169.11
CSL LIMITED
1D-2.10%
1M+19.50%
1Y-48.00%
Track your position in CSL
Sign in to TradeLedgr to record trades in CSL (CSL LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
17 Aug 2026 10:02 PM
CSL Appendix 4G and Corporate Governance Statement5991KB
Corporate Governance
17 Aug 2026 10:01 PM
CSL Results Presentation for FY20262380KB
Company Presentation
17 Aug 2026 10:00 PM
Dividend/Distribution - CSL15KB
Dividend Record Date
17 Aug 2026 10:00 PM
CSL FY2026 Results231KB
Web Cast
17 Aug 2026 9:58 PM
CSL Statutory Accounts for FY20266881KB
Sustainability/Climate Action Report
Fundamentals
P/E Ratio
-99999.99x
Div Yield
242.84%
EPS
$-7.5508
Avg Vol
1.8M
52W High
$228.300
52W Low
$90.000
Company Profile
Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
Financial History
2026A
$-2579.0M profit
$15797.0M rev
2025A
$3002.0M profit
$15558.0M rev
2024A
$2642.0M profit
$14800.0M rev